Gene · 406966
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| miRNAs as predictive biomarkers of response to treatment in pediatric patients with acute lymphoblastic leukemia. | Oncol Lett | 2024 | 38192661 | PubTator, text mining | PubMed |
| MHESMMR: a multilevel model for predicting the regulation of miRNAs expression by small molecules. | BMC Bioinformatics | 2024 | 38166644 | PubTator, text mining | PubMed |
| The muzzle to target distance -staining inside different parts of the firearm barrel. | Int J Legal Med | 2024 | 38091066 | PubTator, text mining | PubMed |
| The platelet storage lesion, what are we working for? | J Clin Lab Anal | 2024 | 38069592 | PubTator, text mining | PubMed |
| Improving targeted small molecule drugs to overcome chemotherapy resistance. | Cancer Rep (Hoboken) | 2024 | 37994401 | PubTator, text mining | PubMed |
| Tumor-mesothelium HOXA11-PDGF BB/TGF β1-miR-181a-5p-Egr1 feedforward amplifier circuity propels mesothelial fibrosis and peritoneal metastasis of gastric cancer. | Oncogene | 2024 | 37989866 | PubTator, text mining | PubMed |
| Association of Trophectoderm mRNAs and MicroRNAs with Chromosomal Aneuploidy of Embryo. | Reprod Sci | 2024 | 37964074 | PubTator, text mining | PubMed |
| Integrating a microRNA signature as a liquid biopsy-based tool for the early diagnosis and prediction of potential therapeutic targets in pancreatic cancer. | Br J Cancer | 2024 | 37950093 | PubTator, text mining | PubMed |
| LncRNAs-circRNAs as Rising Epigenetic Binary Superstars in Regulating Lipid Metabolic Reprogramming of Cancers. | Adv Sci (Weinh) | 2024 | 37939296 | PubTator, text mining | PubMed |
| Exosome regulation of immune response mechanism: Pros and cons in immunotherapy. | Bioact Mater | 2024 | 37927901 | PubTator, text mining | PubMed |
| MicroRNAs as potential biomarkers for diagnosis of attention deficit hyperactivity disorder. | Neural Regen Res | 2024 | 37721284 | PubTator, text mining | PubMed |
| Uncovering transcriptomic biomarkers for enhanced diagnosis of methamphetamine use disorder: a comprehensive review. | Front Psychiatry | 2023 | 38260797 | PubTator, text mining | PubMed |
| Exploring Optimal Biomarker Sources: A Comparative Analysis of Exosomes and Whole Plasma in Fasting and Non-Fasting Conditions for Liquid Biopsy Applications. | Int J Mol Sci | 2023 | 38203541 | PubTator, text mining | PubMed |
| A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma. | Cells | 2023 | 38201207 | PubTator, text mining | PubMed |
| miRNA-mediated control of gephyrin synthesis drives sustained inhibitory synaptic plasticity. | bioRxiv | 2023 | 38168421 | PubTator, text mining | PubMed |
| Functional and Potential Therapeutic Implication of MicroRNAs in Pancreatic Cancer. | Int J Mol Sci | 2023 | 38139352 | PubTator, text mining | PubMed |
| miRNA Expression Profiles in Ovarian Endometriosis and Two Types of Ovarian Cancer-Endometriosis-Associated Ovarian Cancer and High-Grade Ovarian Cancer. | Int J Mol Sci | 2023 | 38139300 | PubTator, text mining | PubMed |
| A Glimmer of Hope for Patients with a T3 Transformation Zone: miRNAs Are Potential Biomarkers for Cervical Dysplasia. | Diagnostics (Basel) | 2023 | 38132183 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Exosomal microRNAs in Cardiac Regeneration. | Cells | 2023 | 38132135 | PubTator, text mining | PubMed |
| Overexpression of microRNA-205-5p promotes cholangiocarcinoma growth by reducing expression of homeodomain-interacting protein kinase 3. | Sci Rep | 2023 | 38105269 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406966/papers?page=5